Diagnostic Performance of the Diaspot® Rapid Diagnostic Test in the Diagnosis of Malaria in the Buea and Limbe Regional Hospitals, South West Region, Cameroon

Malaria is a relentless disease caused by tiny parasites that hitch a ride inside mosquitoes and enter the human bloodstream. When these parasites multiply, they trigger fevers, chills, and headaches, and if left untreated, they can be fatal. For decades, doctors have relied on a few key tools to find the enemy. The most traditional method involves taking a drop of blood, spreading it on a glass slide, staining it with a purple dye, and looking for the parasites under a powerful microscope. This approach has been the standard for over a century, but it demands a highly skilled eye and can miss infections where the parasite count is very low. A newer, faster alternative is the rapid diagnostic test, a small plastic cassette that works like a pregnancy test, using a drop of blood to detect specific proteins left behind by the parasite. While these tests are quick and easy to use in remote areas, scientists have long debated whether they are accurate enough to replace the microscope, especially in places where malaria is common year-round. The ultimate truth-teller in this field is a molecular technique called polymerase chain reaction, which acts like a magnifying glass for DNA, capable of finding the genetic signature of the parasite even when it is hiding in numbers too small for any other tool to see.

In the South West Region of Cameroon, where malaria transmission is high and constant, researchers set out to settle the question of which tool performs best in real-world hospitals. They focused on two major medical centers, the Regional Hospital in Buea and the Regional Hospital in Limbe, both situated on the slopes of Mount Cameroon. Between October 2023 and May 2024, the team recruited 223 patients who had come to these hospitals with fevers and other symptoms of malaria. The goal was not just to count how many people were sick, but to see how well the rapid test and the microscope could identify the disease when compared against the gold standard of molecular testing. For every patient, the medical team collected a small amount of blood and split it to be tested three different ways: using the Diaspot rapid test, by preparing stained slides for a microscope, and by sending a sample to a laboratory to be analyzed for parasite DNA.

The results painted a clear picture of the strengths and weaknesses of each method. When the researchers used the molecular test as the baseline for truth, they found that it detected malaria in 131 of the 223 patients, revealing a prevalence of nearly 59 percent. The rapid test performed impressively well, correctly identifying 123 of these cases. In contrast, the microscope, despite being the traditional standard, missed more cases, finding only 104 positive results. The rapid test proved to be significantly more sensitive than the microscope, meaning it was far better at catching the disease when it was actually present. Specifically, the rapid test correctly identified 93.1 percent of the true cases, while the microscope only caught 77.9 percent. This difference mattered because the microscope missed 22 patients who the rapid test and the molecular test both confirmed were infected. In a clinical setting, missing these cases could mean a patient leaves the hospital without the life-saving medication they need.

The study also looked at how often the tests gave false alarms. Both methods were excellent at this, with the rapid test and the microscope showing very similar rates of specificity, meaning they rarely told a healthy person they were sick. However, the rapid test was much better at reassuring people who did not have the disease. If a patient tested negative on the rapid test, there was a 91 percent chance they were truly free of malaria, whereas a negative result on the microscope only carried a 75.6 percent chance of being correct. This made the rapid test a more reliable tool for ruling out the disease. The agreement between the rapid test and the molecular gold standard was nearly perfect, whereas the agreement between the microscope and the gold standard was good but noticeably lower.

There were interesting variations depending on where the patients were treated. At the hospital in Buea, the rapid test was almost flawless, catching 98.4 percent of the cases. At the hospital in Limbe, it was still very effective but slightly less so, catching 88.1 percent. The researchers noted that the microscope struggled even more at the Limbe site, missing a significant number of infections compared to the rapid test. The study also uncovered a small but important detail: the rapid test detected six cases of a different type of malaria parasite, Plasmodium vivax, which is less common in this region of Africa. The molecular test used in the study was designed only to look for the most common type, Plasmodium falciparum, so it could not confirm these specific vivax cases, but their presence suggests the rapid test might be spotting infections that other methods would overlook entirely.

Despite the rapid test's superior performance, the study highlighted that no single tool is perfect. Even the molecular test, which is the most sensitive method available, found cases that the rapid test missed. These were likely infections with such low numbers of parasites that they fell below the detection limit of the rapid test. This finding suggests that while the rapid test is a massive improvement over the microscope for routine care, it cannot yet replace the need for advanced molecular tools in surveillance programs. The researchers concluded that hospitals in this region should continue to use high-quality rapid tests for diagnosing febrile patients, as they are far more accurate than the microscope. However, to truly understand the full scope of malaria in the community and to catch the hidden, low-level infections, these facilities need to integrate molecular testing into their regular monitoring. The study also pointed out the need for better training for microscope operators and ongoing checks to ensure the rapid tests remain effective, as the parasites can sometimes change in ways that make them harder to detect. Ultimately, the work in Buea and Limbe confirms that while the rapid test is a powerful ally in the fight against malaria, a combination of tools remains the best strategy for saving lives.